Abstract
In anesthetized guinea pigs, we examined heart rate, arterial pressure, and GABA levels in four brain regions after systemic administration of 3-mercaptopropionic acid, an inhibitor of GABA synthesis. After i.p. injection of 195 mg/kg, significant reductions in GABA were first noted at 15 minutes in the cerebellum (−39%), 30 minutes in the hypothalamus (−27%), 60 minutes in the medulla pons (−34%) and 90 minutes in the cerebral cortex (−43%). Cardiovascular function was unaltered at 15 minutes but heart rate and arterial pressure were both significantly elevated at 30 minutes. By 60 minutes, however, heart rate had fallen below control. Injection of a lower dose (97.5 mg/kg i.p.) of 3-MP produced significant increases in heart rate and arterial pressure in 4 of 11 guinea pigs tested. When GABA levels in the same four brain regions were examined at 90 minutes and compared to corresponding levels from vehicle-treated guinea pigs, significant reductions were seen only in the hypothalamus and only in those animals displaying tachycardia and pressor responses. These findings are consistent with our previous results indicating that decreased GABA levels in the hypothalamus and in the medulla pons are responsible for the increases and decreases in heart rate, respectively, seen after systemic administration of 3-mercaptopropionic acid.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
DiMicco, J. A., Gale, K., Hamilton, B. L., and Gillis, R. A. 1979. GABA receptor control of parasympathetic outflow to the heart: Characterization and brainstem localization. Science 204:1106–1109.
Wible, J. H., Jr., and DiMicco, J. A. 1986. Biphasic effects of systemically administered GABA antagonists on cardiac vagal activity. Brain Research 363:279–289.
Lee, T. M., Yang, K. L., Kuo, J. S., and Choi, C. Y. 1972. Importance of sympathetic mechanisms on cardiac arrhythmias produced by picrotoxin. Exp. Neurol. 36:389–398.
Schmidt, B., and DiMicco, J. A. 1984. Blockade of GABA receptors in periventricular forebrain of anesthetized cats: Effects on heart rate, arterial pressure, and hindlimb vascular resistance. Brain Research 301:111–119.
DiMicco, J. A., and Abshire, V. M. 1987. Evidence for GABAergic inhibition of a hypothalamic sympathoexcitatory mechanism in anesthetized rats. Brain Research 401:1–10.
Sample, R. H. B., and DiMicco, J. A. 1987. Localization of sites in periventricular forebrain mediating cardiovascular effects of gamma-aminobutyric acid agonists and antagonists in anesthetized cats. J. Pharmacol. Exp. Ther. 240:498–507.
Wible, J. H., Jr., Luft, F. C., and DiMicco, J. A. 1988. Hypothalamic GABA suppresses sympathetic outflow to the cardiovascular system. Am J. Physiol. 254:R680–687.
Lamar, C. 1970. Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J. Neurochemistry 17:165–170.
Alsip, N. L., Simon, J. R., Pohl, L. D., and DiMicco, J. A. 1984. Cardiovascular effects of 3-mercaptopropionic acid and levels of GABA in regions of the brain of guinea pigs. Neuropharmacology 23:349–357.
Roberts, F., Taberner, P. V., and Hill, R. G. 1978. The effect of 3-mercaptopropionate, an inhibitor of glutamate decarboxylase, on the levels of GABA and other amino acids, and on presynaptic inhibition in the rat cuneate nucleus. Neuropharmacology 17:715–720.
Karlsson, A., Fonnum, F., Malthe-Sorenssen, D., and Storm-Mathison, J. 1974. Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids, and glutamate decarboxylase in different regions of the rat brain. Biochem. Pharmacol. 23:3053–3061.
Kehr, J., and Ungerstedt, U. 1988. Fast HPLC estimation of gamma-aminobutyric acid in microdialysis perfusates: effect of nipecotic and 3-mercaptopropionic acids. J. Neurochemistry 51:1308–1310.
Fan, S. G., Wusteman, M., and Iversen, L. L. 1981. 3-Mercaptopropionic acid inhibits GABA release from rat brain slices in vitro. Brain Res. 229:371–377.
Kerwin, R. W., and Meldrum, B. S. 1983. Effect on cerebral D-[3H]aspartate release of 3-mercaptopropionic acid and methyl-6,7-dimethoxy-4-ethyl-beta carboline-3-carboxylate. Eur. J. Pharmacol. 89:265–269.
Van der Heyden, J. A. M., and Korf, J. 1978. Regional levels of GABA in the brain: Rapid automated assay and prevention of postmortem increase by 3-mercaptopropionic acid. J. Neurochem. 31:197–203.
Graham, L. T., and Aprison, M. H. 1966. Fluorometric determination of aspartate, glutamate, and gamma aminobutyric acid in nerve tissue using enzymatic methods. Analyt. Biochem. 15:487–497.
Balcom, G. J., Lenox, R. H., Meyerhoff, J. L. 1975. Regional gamma-aminobutyric acid levels in rat brain determined after microwave fixation. J. Neurochem. 24:609–613.
Abshire, V. M., Hankins, K. D., Roehr, K. E., and DiMicco, J. A. 1988. Injection ofl-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate. Neuropharmacology 27:1171–1177.
DiMicco, J. A., Alsip, N. L., and Wible, J. H., Jr. 1984. Multiple roles for CNS GABA mechanisms in the autonomic regulation of cardiovascular function: Pharmacologic evidence. Neuropharmacology 23:819–820.
DiMicco, J. A. 1982. Blockade of forebrain GABA receptors and reflex activation of the cardiac vagus in anesthetized cats. J. Pharmacol. Exp. Ther. 233:654–661.
Bauer, R. M., Vela, M. B., Simon, T., and Waldrop, T. G. 1988. A GABAergic mechanism in the posterior hypothalamus modulates baroreflex bradycardia. Brain Res. Bull. 20:633–641.
Williford, D. J., Hamilton, B. L., and Gillis, R. A. 1980. Evidence that a GABAergic mechanism at nucleus ambiguous influences reflex-induced vagal activity. Brain Res. 193:584–588.
Barman, S. M., and Gebber, G. L. 1979. Picrotoxin- and bicuculline-sensitive inhibition of cardiac vagal reflexes. J. Pharmacol. Exp. Ther. 209:67–72.
Kuriyama, K., Roberts, E., and Rubinstein, M. K. 1966. Elevation of GABA in brain with amino-oxyacetic acid and susceptibility to convulsive seizures in mice: A quantitative reevaluation. Biochem. Pharmacol. 15:221–236.
Iadarola, M. J., and Gale, K. 1979. Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo. Eur. J. Pharmacol. 59:125–129.
Geddes, J. W., and Wood, J. D. 1984. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma aminobutyric acid. J. Neurochem. 42:16–24.
Loscher, W., and Vetter, M. 1984. Relationship between drug-induced increases of GABA levels in discrete brain areas and different pharmacological effects in rats. Biochem. Pharmacol. 33:1907–1914.
Loscher, W., and Vetter, M. 1985. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Biochem. Pharmacol. 34:1747–1756.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Morris H. Aprison
Rights and permissions
About this article
Cite this article
Alsip, N.L., DiMicco, J.A. Time course of effects of 3-mercaptopropionic acid on GABA levels in different brain regions in guinea pigs: Possible relationship with associated cardiovascular changes. Neurochem Res 17, 443–448 (1992). https://doi.org/10.1007/BF00969890
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969890